V Jacquelin1, A Mekinian2, P Y Brillet3, H Nunes4, O Fain2, D Valeyre4, M Soussan5. 1. AP-HP, Hosp. Avicenne, Department of Nuclear Medicine, Bobigny, France. 2. AP-HP, Hosp. Saint-Antoine, Department of Internal Medicine and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France. 3. AP-HP, Hosp. Avicenne, Department of Radiology, Bobigny, France; Univ. Paris 13, Sorbonne Paris Cité, Bobigny, France. 4. AP-HP, Hosp. Avicenne, Department of Pneumology, Bobigny, France; Univ. Paris 13, Sorbonne Paris Cité, Bobigny, France. 5. AP-HP, Hosp. Avicenne, Department of Nuclear Medicine, Bobigny, France; Univ. Paris 13, Sorbonne Paris Cité, Bobigny, France. Electronic address: michael.soussan@aphp.fr.
Abstract
PURPOSE: Our study aimed to analyse the characteristics of nonspecific interstitial pneumonia (NSIP) using FDG-PET/CT (PET) and to evaluate its ability to predict the therapeutic response. PROCEDURES: Eighteen NSIP patients were included. Maximum standardized uptake value (SUVmax), FDG uptake extent (in percentage of lung volume), high resolution CT scan (HRCT) elementary lesions, and HRCT fibrosis score were recorded. The predictive value of the parameters for lung function improvement was evaluated using logistic regression and Receiver Operating Characteristic (ROC) curve analysis (n=13/18). RESULTS: All patients had an increased pulmonary FDG uptake (median SUVmax=3.1 [2-7.6]), with a median extent of 19% [6-67]. Consolidations, ground-glass opacities, honeycombing and reticulations showed uptake in 90%, 89%, 85% and 76%, respectively. FDG uptake extent was associated with improvement of pulmonary function under treatment (increase in forced vital capacity>10%, p=0.03), whereas SUVmax and HRCT fibrosis score were not (p>0.5). For FDG uptake extent, ROC analysis showed an area under the curve at 0.85±0.11 and sensitivity/specificity was 88%/80% for a threshold fixed at 21%. CONCLUSIONS: Increased FDG uptake was observed in all NSIP patients, both in inflammatory and fibrotic HRCT lesions. The quantification of FDG uptake extent might be useful to predict functional improvement under treatment.
PURPOSE: Our study aimed to analyse the characteristics of nonspecific interstitial pneumonia (NSIP) using FDG-PET/CT (PET) and to evaluate its ability to predict the therapeutic response. PROCEDURES: Eighteen NSIP patients were included. Maximum standardized uptake value (SUVmax), FDG uptake extent (in percentage of lung volume), high resolution CT scan (HRCT) elementary lesions, and HRCT fibrosis score were recorded. The predictive value of the parameters for lung function improvement was evaluated using logistic regression and Receiver Operating Characteristic (ROC) curve analysis (n=13/18). RESULTS: All patients had an increased pulmonary FDG uptake (median SUVmax=3.1 [2-7.6]), with a median extent of 19% [6-67]. Consolidations, ground-glass opacities, honeycombing and reticulations showed uptake in 90%, 89%, 85% and 76%, respectively. FDG uptake extent was associated with improvement of pulmonary function under treatment (increase in forced vital capacity>10%, p=0.03), whereas SUVmax and HRCT fibrosis score were not (p>0.5). For FDG uptake extent, ROC analysis showed an area under the curve at 0.85±0.11 and sensitivity/specificity was 88%/80% for a threshold fixed at 21%. CONCLUSIONS: Increased FDG uptake was observed in all NSIP patients, both in inflammatory and fibrotic HRCT lesions. The quantification of FDG uptake extent might be useful to predict functional improvement under treatment.
Authors: Hyung Ju Lee; Hye Joo Son; Mijin Yun; Jung Won Moon; Yoo Na Kim; Ji Young Woo; Suk Hyun Lee Journal: Eur Radiol Date: 2021-04-14 Impact factor: 5.315
Authors: Daphne M Peelen; Ben G J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Otto S Hoekstra; Conny J Van der Laken; Alexandre E Voskuyl Journal: Rheumatology (Oxford) Date: 2020-06-01 Impact factor: 7.580
Authors: Nicholas D Weatherley; James A Eaden; Neil J Stewart; Brian J Bartholmai; Andrew J Swift; Stephen Mark Bianchi; Jim M Wild Journal: Thorax Date: 2019-03-18 Impact factor: 9.139
Authors: Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin Journal: Arthritis Res Ther Date: 2021-03-06 Impact factor: 5.156
Authors: Bo Broens; Conny J van der Laken; Gerben J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Julia Spierings; Jeska K de Vries-Bouwstra; Jacob M van Laar; Alexandre E Voskuyl Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786